as on December 22, 2025 at 11:38 pm IST
Day's Low
Day's High
3.75%
Downside
2.32%
Upside
52 Week's Low
52 Week's High
79.43%
Downside
47.64%
Upside
Check Structure Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.6B
EPS (TTM)
-1.3855
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-246.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-25.28%
Compare market cap, revenue, PE, and other key metrics of Structure Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.6B | NA | NA | 0.00% | |
| BUY | $37.3B | 385.94% | -16.34 | -264.83% | |
| BUY | $52.9B | 189.37% | 1429.39 | 1.36% | |
| BUY | $117.0B | 94.21% | 32.15 | 31.35% | |
| BUY | $81.4B | 56.71% | 18.42 | 32.13% |
The Structure Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Structure Therapeutics, Inc. investment value today
Current value as on today
₹2,35,816
Returns
₹1,35,816
(+135.82%)
Returns from Structure Therapeutics, Inc. Stock
₹1,30,394 (+130.39%)
Dollar Returns*
₹5,422 (+5.42%)
Based on 14 analysts
92.86%
Buy
7.14%
Hold
0.00%
Sell
Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Structure Therapeutics, Inc.. Average target price of $99.43
Get share price movements and forecasts by analysts on Structure Therapeutics, Inc..
What analysts predicted
35.35%UPSIDE
Target Price
$99.43
Current Price
$64.28
Analyzed by
14 Analysts
Target
$99.43
Structure Therapeutics, Inc. target price $99.43, a slight upside of 35.35% compared to current price of $64.28. According to 14 analysts rating.
Investment in Structure Therapeutics, Inc. Shares on INDmoney has grown by 206.45% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:206.45% versus previous 30 day period
Search interest for Structure Therapeutics, Inc. Stock has increased by 425% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:425% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 08 December
Mon, 11:05 PM
-Structure Therapeutics' obesity pill shows up to 11% weight loss after 36 weeks, boosting shares nearly double.
Tue, 02:31 AM
-Structure Therapeutics announces proposed $500 million public offering of American Depositary Shares and pre-funded warrants.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, GPCR stock has moved up by 89.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 148.2% return, outperforming this stock by 15.4%
| Organisation | Structure Therapeutics, Inc. |
| Headquarters | 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Healthcare |
| CEO | Dr. Raymond C. Stevens Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Fang Zhang Ph.D. | Executive VP & Head of Biology |
Ms. Lani Ibarra | Senior Vice President of Clinical Development Operations |
Dr. Xichen Lin Ph.D. | Chief Scientific Officer & GM of Structure Shanghai |
Mr. Jun S. Yoon | Co- Founder, CFO & Secretary |
Mr. Tony Peng | Senior Vice President of Legal |
Dr. Hui Lei Ph.D. | Senior Vice President of Chemistry |
Dr. Raymond C. Stevens Ph.D. | CEO & Director |
Dr. Blai Coll M.D., Ph.D. | Chief Medical Officer |
Dr. Yingli Ma Ph.D. | Chief Technology Officer |
Mr. Bob Gatmaitan | Senior Vice President of People |
Structure Therapeutics, Inc. share price today is $64.28 as on . Structure Therapeutics, Inc. share today touched a day high of $65.77 and a low of $61.87.
Structure Therapeutics, Inc. share touched a 52 week high of $94.9 on and a 52 week low of $13.22 on . Structure Therapeutics, Inc. stock price today i.e. is trending at $64.28,which is 32.27% down from its 52 week high and 386.23% up from its 52 week low.
Structure Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Structure Therapeutics, Inc. (GPCR) shares with as little as ₹89.714 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.14 in Structure Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Structure Therapeutics, Inc. share’s latest price of $64.28 as on December 22, 2025 at 11:38 pm IST, you will get 0.1556 shares of Structure Therapeutics, Inc.. Learn more about
fractional shares .